Combination of Plasma Beta Amyloid 42/40 and P-tau217 in the Assessment of Alzheimer’s Disease
Congratulations to Drs. Melissa Armstrong and David Vaillencourt, on the publication of “Combination of Plasma Beta Amyloid 42/40 and P-tau217 in the Assessment of Alzheimer’s Disease, ” which appears in the April edition of Neurology. Abstract Background: Up to now, there are no clinically available minimally invasive biomarkers to accurately identify…